How can exosomes break through the limits of traditional cancer therapies and lead regenerative medicine into a new era? When gene engineering meets exosome technology, could it be redefining the future of health and longevity? 　We extend our sincere gratitude to our global partners for witnessing the successful expansion of Invitrx. As we conclude a remarkable 2025, we look forward to driving further innovation across the region in 2026.